Negative regulation of cytokine signaling

Journal of Leukocyte Biology

Volumn 70, Issue 3, 2001, Pages 348-356

  Greenhalgh, Christopher J ^a,b   Hilton, Douglas J ^a  

^a University of Melbourne   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Janus kinase; Phosphatase; PIAS; SOCS; STAT

Indexed keywords

CD45 ANTIGEN; CYTOKINE; JANUS KINASE; PHOSPHATASE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

DIMERIZATION; DNA BINDING; ENZYME ACTIVITY; KNOCKOUT MOUSE; NEGATIVE FEEDBACK; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC ANIMAL;

ANIMALS; CARRIER PROTEINS; CYTOKINES; DNA-BINDING PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MODELS, BIOLOGICAL; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN-TYROSINE-PHOSPHATASE; PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0034841006     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Signaling by the cytokine receptor superfamily
2. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
3. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene
4. DNA-binding antibodies from viable motheaten mutant mice: Implications for B cell tolerance
5. The viable motheaten (mev) mouse - A new model for arthritis
6. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling
7. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: Detection of potential HCP substrates in GM-CSF signal transduction
8. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1
9. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
10. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: Identification of potential binding sites
11. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1
12. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1
13. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis
14. The CD45 tyrosine phosphatase: A positive and negative regulator of immune cell function
15. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
16. A family of cytokine-inducible inhibitors of signalling
17. A new protein containing an SH2 domain that inhibits JAK kinases
18. Structure and function of a new STAT-induced STAT inhibitor
19. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors
20. Twenty proteins containing a C-terminal SOCS box form five structural classes
21. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation
22. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling
23. Leptin treatment increases suppressors of cytokine signaling in central and peripheral tissues
24. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling
25. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo
26. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction
27. Activation of SOCS-3 messenger ribonucleic acid in the hypothalamus by ciliary neurotrophic factor
28. CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling
29. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone
30. SOCS-1, -2, -3: Selective targets and functions downstream of the prolactin receptor
31. Cloning and characterization of novel CIS family genes
32. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells
33. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine
34. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities
35. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction
36. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts
37. Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1
38. Interleukin 9 induces expression of three cytokine signal inhibitors: Cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling
39. Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines
40. IL-10 attenuates IFN-alpha-activated STAT1 in the liver: Involvement of SOCS2 and SOCS3
41. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms
42. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3
43. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor
44. Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1beta on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells
45. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: Evidence for an IL-10-induced pathway that is independent of STAT protein activation
46. Interleukin-11 stimulates pro-opiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: Evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis
47. Identification of SOCS-3 as a potential mediator of central leptin resistance
48. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-gamma
49. SOCS-3 is an insulin-induced negative regulator of insulin signaling
50. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2
51. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation
52. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction
53. Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3)
54. The role of SOCS-3 in leptin signaling and leptin resistance
55. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor
56. A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs
57. Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat
58. Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor
59. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
60. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins
61. Cis desensitizes GH induced Stat5 signaling in rat liver cells
62. The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families
63. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation
64. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling
65. Negative regulation of early B lymphopoiesis by interleukin 3 and interleukin 1 alpha
66. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis
67. Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin
68. Regulation of insulin-like growth factor-1 (IGF-I) and IGF-binding proteins by tumor necrosis factor
69. Interleukin-10
70. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages
71. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1
72. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1
73. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice
74. Can interferon induce disease?
75. Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice
76. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality
77. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation
78. Defective thymocyte development and perturbed homeostasis of T cells in STAT-induced STAT inhibitor-1/suppressors of cytokine signaling-1 transgenic mice
79. Gigantism in mice lacking suppressor of cytokine signalling-2
80. Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver
81. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
82. Normal growth and development in the absence of hepatic insulin-like growth factor I
83. SOCS3 is essential in the regulation of fetal liver erythropoiesis
84. Stat5a is mandatory for adult mammary gland development and lactogenesis
85. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
86. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
87. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice
88. Inhibition of Stat1-mediated gene activation by PIAS1
89. Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS/-Stat1 interaction
90. Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription
91. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer
92. Specific inhibition of Stat3 signal transduction by PIAS3